On ECHEMI
Home > Drugs > Osteogenesis imperfecta
Osteogenesis imperfecta
Osteogenesis imperfecta is a rare congenital bone development disorder, also known as brittle bone disease or brittle bone-blue sclera-deafness syndrome. It is characterized by fragile bones, blue sclera, deafness, and joint laxity. It is a congenital hereditary pain caused by incomplete development of mesenchymal tissue and collagen formation disorder. The lesions are not limited to bones, but often involve other connective tissues such as eyes, ears, skin, teeth, etc. This disease is hereditary and familial, but there are also a few single cases.
  • Site of disease:

    Bone Eyes and Ears
  • Infectious :

    Not contagious
  • Frequent population:

    All groups
  • Related symptoms:

    Brittle bones blue sclera joint relaxation neural deafness abnormal development of bone marrow
Related Drugs
Licorice Zinc Capsules
Indication: Anorexia, pica, and poor growth and development in children caused by zinc deficiency. Oral ulcers.
Manufacturer:

Chifeng Weikang Biochemical Pharmaceutical Co., Ltd.

Oyster Calcium Carbonate Chewable Tablets
Indication: Used for calcium supplementation in children, pregnant or lactating women, menopausal women and the elderly.
Manufacturer:

Gai Tianli Pharmaceutical Holdings Group Pharmaceutical Co., Ltd.

Oyster calcium carbonate granules
Indication: 1. Treatment of rickets in children. Suitable for calcium supplementation during the growth period of children and prevention of bone and tooth dysplasia caused by calcium deficiency in children.
Manufacturer:

Gai Tianli Pharmaceutical Holdings Group Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.